Result 1 - 10 of total 826
The Dental register
2021 Volume 37, Issue 1, Page(s) 38–40
| Language | English |
|---|---|
| Publishing date | 2021-03-10 |
| Publishing country | United States |
| Document type | Journal Article |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.
2018 Volume 27, Issue 1_suppl, Page(s) 8–10
| MeSH term(s) | Adrenal Cortex Hormones/therapeutic use ; Anti-Inflammatory Agents, Non-Steroidal/therapeutic use ; Azathioprine/therapeutic use ; Disease Management ; Humans ; Hydroxychloroquine/therapeutic use ; Lupus Erythematosus, Systemic/drug therapy ; Methotrexate/therapeutic use ; Mycophenolic Acid/therapeutic use ; Rituximab/therapeutic use |
|---|---|
| Chemical Substances | Adrenal Cortex Hormones ; Anti-Inflammatory Agents, Non-Steroidal ; Rituximab (4F4X42SYQ6) ; Hydroxychloroquine (4QWG6N8QKH) ; Mycophenolic Acid (HU9DX48N0T) ; Azathioprine (MRK240IY2L) ; Methotrexate (YL5FZ2Y5U1) |
| Language | English |
| Publishing date | 2018-11-16 |
| Publishing country | England |
| Document type | Journal Article |
| ZDB-ID | 1154407-7 |
| ISSN | 1477-0962 ; 0961-2033 |
| ISSN (online) | 1477-0962 |
| ISSN | 0961-2033 |
| DOI | 10.1177/0961203318801670 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
| Zs.A 3717: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.
Australian journal of primary health
2023 Volume 29, Issue 6, Page(s) 643–649
Abstract: Background: Worldwide, responsibility for dementia diagnosis and management is shifting to primary care, in particular to the general practitioner (GP). It has been acknowledged that primary care nurses, working collaboratively with GPs, have a role in ... ...
| Abstract | Background: Worldwide, responsibility for dementia diagnosis and management is shifting to primary care, in particular to the general practitioner (GP). It has been acknowledged that primary care nurses, working collaboratively with GPs, have a role in dementia care by utilising their unique knowledge and skills. However, there are no best-practice guidelines or care pathways to inform nurses in general practice on what best-practice dementia care comprises and how to implement this into their practice. This study identified the recommendations in the Australian guidelines for dementia management most relevant to the role of the nurse working in general practice. Methods: Seventeen experts active in clinical practice and/or research in primary care nursing in general practice participated in an online three-round Delphi study. Results: All 17 participants were female with a nursing qualification and experienced in general practice clinical nursing and/or general practice nursing research. Five recommendations were identified as the most relevant to the role of the nurse in general practice. These recommendations all contained elements of person-centred care: the delivery of individualised information, ongoing support, including the carer in decision-making, and they also align with the areas where GPs want support in dementia care provision. Conclusion: This novel study identified best-practice dementia care recommendations specific to nurses in general practice. These recommendations will inform a model of care for nurses in the provision of dementia care that supports GPs and better meets the needs of people living with dementia and their carer(s). |
|---|---|
| MeSH term(s) | Humans ; Female ; Male ; Delphi Technique ; Australia ; General Practice ; General Practitioners ; Dementia/therapy |
| Language | English |
| Publishing date | 2023-06-19 |
| Publishing country | Australia |
| Document type | Journal Article |
| ZDB-ID | 2566332-X |
| ISSN | 1836-7399 ; 1448-7527 |
| ISSN (online) | 1836-7399 |
| ISSN | 1448-7527 |
| DOI | 10.1071/PY22276 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.
The Australian journal of rural health
2023 Volume 31, Issue 6, Page(s) 1229–1239
Abstract: Introduction: In response to COVID-19 and mandated physical distancing, a new digital social connection program was developed and implemented by the local community in a large regional town in western Victoria, Australia. This pilot program, the Digital ...
| Abstract | Introduction: In response to COVID-19 and mandated physical distancing, a new digital social connection program was developed and implemented by the local community in a large regional town in western Victoria, Australia. This pilot program, the Digital Inclusion-Social Connections (DI-SC) program, aimed to support people living with dementia to use a digital device to access social connection activities. Objective: The objective of this study is to inform the local community implementing the DI-SC program of key stakeholder experience of DI-SC process and outcomes to support future development and potential translation of digital social connections programs for people living with dementia. Design: Three semi-structured focus groups and two interviews were conducted with a total of fifteen participants. Data was transcribed verbatim and thematically analysed. Findings: Three main themes were identified describing factors as influencing the process and outcomes of the DI-SC program: understanding dementia; personal choice and control; and service planning and coordination. Six sub-themes were identified: matching capability; establishing a relationship; creating opportunities for different interactions; ownership of the device, program coordination and defining the volunteer digital mentor role. Conclusion: Key stakeholders perceived the DI-SC program as an acceptable way of supporting people living with dementia to engage in activities they found enjoyable promoting social connection with care partners and others. DI-SC program outcomes were impacted by inappropriate training and a lack of program coordination. The findings of this study may inform future development and implementation of digital social connection programs for vulnerable populations at risk of social isolation. |
|---|---|
| MeSH term(s) | Humans ; Pilot Projects ; Qualitative Research ; Social Behavior ; Victoria ; Dementia/therapy |
| Language | English |
| Publishing date | 2023-10-14 |
| Publishing country | Australia |
| Document type | Journal Article |
| ZDB-ID | 2069573-1 |
| ISSN | 1440-1584 ; 1038-5282 |
| ISSN (online) | 1440-1584 |
| ISSN | 1038-5282 |
| DOI | 10.1111/ajr.13052 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.
Journal of the American Pharmacists Association : JAPhA
2023 Volume 64, Issue 2, Page(s) 557–563
Abstract: Background: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for weight management require frequent dose titration, patient education, and insurance coverage navigation, which pharmacists are well equipped to manage. Data are lacking regarding the ... ...
| Abstract | Background: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for weight management require frequent dose titration, patient education, and insurance coverage navigation, which pharmacists are well equipped to manage. Data are lacking regarding the benefit of a pharmacist-managed service using GLP-1 RAs for weight loss in a high-risk cardiac population. Objective: This study aimed to evaluate the impact of a pharmacist-led weight loss service within a cardiology clinic using GLP-1 RAs and lifestyle counseling in patients with overweight and obesity. Practice description: An outpatient cardiology clinic employs clinical pharmacists who use collaborative practice agreements to provide cardiovascular risk reduction services that did not include weight management at baseline. Practice innovation: This is the first description of a pharmacist-led weight management clinic using solely GLP-1 RAs in a cardiology practice. Patients were referred to the clinical pharmacist, who initiated and titrated GLP-1 RA and provided lifestyle counseling. Evaluation methods: This was a single-center, prospective, pre-post analysis of adults with a body mass index of at least 30 kg/m Results: Between March 2022 and March 2023, 204 patients were referred by their cardiologist, and 59 patients started treatment with semaglutide (Wegovy, Novo Nordisk) or liraglutide (Saxenda, Novo Nordisk). A total of 31 patients completed 6 months of treatment at time of study completion, and all achieved ≥ 5% weight loss at 6 months, with a mean weight loss of 12.6%. Glycated hemoglobin improved by 0.6%, low-density lipoprotein by 18 mg/dL, triglycerides by 29 mg/dL, systolic blood pressure by 9 mm Hg, and diastolic blood pressure by 2 mm Hg. Conclusion: Pharmacist-led management of GLP-1 RA in patients with obesity or overweight led to clinically meaningful weight loss and improvements in weight-related comorbidities. |
|---|---|
| MeSH term(s) | Adult ; Humans ; Hypoglycemic Agents/therapeutic use ; Pharmacists ; Liraglutide/adverse effects ; Overweight/chemically induced ; Overweight/drug therapy ; Prospective Studies ; Treatment Outcome ; Obesity/drug therapy ; Glucagon-Like Peptide 1/therapeutic use ; Cardiology ; Weight Loss ; Diabetes Mellitus, Type 2/drug therapy |
| Chemical Substances | Hypoglycemic Agents ; Liraglutide (839I73S42A) ; Glucagon-Like Peptide 1 (89750-14-1) |
| Language | English |
| Publishing date | 2023-11-08 |
| Publishing country | United States |
| Document type | Journal Article |
| ZDB-ID | 2118585-2 |
| ISSN | 1544-3450 ; 1544-3191 ; 1086-5802 |
| ISSN (online) | 1544-3450 |
| ISSN | 1544-3191 ; 1086-5802 |
| DOI | 10.1016/j.japh.2023.11.011 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
| Zs.A 1042: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.
2019 Volume 22, Issue 5, Page(s) 608
| Language | English |
|---|---|
| Document type | Article |
| ZDB-ID | 2240542-2 |
| ISSN | 1552-8014 |
| Database | Current Contents Nutrition, Environment, Agriculture |
| Z 7677: Show issues |
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.
Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.
2022 Volume 31, Issue 3, Page(s) 132–135
Abstract: We describe a female infant with X-linked chondrodysplasia punctata (CDPX1) as a result of maternal isodisomy of the X chromosome. Targeted Sanger sequencing and targeted next-generation sequencing of ARSL were used to test for the familial variant. This ...
| Abstract | We describe a female infant with X-linked chondrodysplasia punctata (CDPX1) as a result of maternal isodisomy of the X chromosome. Targeted Sanger sequencing and targeted next-generation sequencing of ARSL were used to test for the familial variant. This patient was homozygous for ARSL NM_000047.2: c.1227_1228delinsAT p.(Ser410Cys) familial variant, consistent with a diagnosis of CDPX1. Uniparental disomy is a type of chromosomal variation. Although not necessarily pathogenic, it can cause imprinting disorders and X-linked recessive disorders in females, and be a cause of autosomal recessive conditions when only one parent is a carrier. The patient described highlights that uniparental disomy can be a rare cause of X-linked recessive conditions. This mode of inheritance has not been previously described in this condition. |
|---|---|
| MeSH term(s) | Chondrodysplasia Punctata/diagnosis ; Chondrodysplasia Punctata/genetics ; Female ; Genetic Diseases, X-Linked ; Homozygote ; Humans ; Infant ; Uniparental Disomy/genetics |
| Language | English |
| Publishing date | 2022-03-07 |
| Publishing country | England |
| Document type | Journal Article |
| ZDB-ID | 1121482-x |
| ISSN | 1473-5717 ; 0962-8827 |
| ISSN (online) | 1473-5717 |
| ISSN | 0962-8827 |
| DOI | 10.1097/MCD.0000000000000419 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
| Zs.A 3528: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.
2022 Volume 24, Issue 4, Page(s) 111–117
Abstract: Purpose of review: Plasma exchange (PLEX) is often recommended as an adjunctive therapy for patients with ANCA-associated vasculitis (AAV) in the setting of rapidly progressive glomerulonephritis or diffuse alveolar haemorrhage. Since ANCAs are ... ...
| Abstract | Purpose of review: Plasma exchange (PLEX) is often recommended as an adjunctive therapy for patients with ANCA-associated vasculitis (AAV) in the setting of rapidly progressive glomerulonephritis or diffuse alveolar haemorrhage. Since ANCAs are pathogenic, it seems a reasonable and justified approach to remove them through therapeutic PLEX, as despite advances in immunosuppressive therapy regimens, AAV is associated with significant morbidity and death. However, the association between ANCA levels and mortality or disease activity is uncertain. In addition, any treatment must be judged on the potential risks and benefits of its use. Here, we summarise the current data on PLEX usage in patients with AAV. Recent findings: The largest randomised trial to date the Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis (PEXIVAS) study failed to show added benefit for PLEX on the prevention of death or end-stage renal failure (ESRF) for the management of patients with severe AAV. However, there is a possibility that PLEX delays dialysis dependence and ESRF in the early stages of the disease. Regardless of whether this is only for 3 to 12 months, this could be of clinical significance and a substantial improvement in patient's quality of life. Cost utility analysis and trials including patient-centred outcomes are required to evaluate the use of PLEX. Furthermore, ascertaining those at high risk of developing ESRF could help identify those who may benefit from PLEX the most, and further insights are required in setting of diffuse alveolar haemorrhage. |
|---|---|
| MeSH term(s) | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/complications ; Antibodies, Antineutrophil Cytoplasmic ; Hemorrhage/etiology ; Hemorrhage/therapy ; Humans ; Kidney Failure, Chronic/complications ; Kidney Failure, Chronic/prevention & control ; Lung Diseases/etiology ; Plasma Exchange/adverse effects ; Quality of Life |
| Chemical Substances | Antibodies, Antineutrophil Cytoplasmic |
| Language | English |
| Publishing date | 2022-03-22 |
| Publishing country | United States |
| Document type | Journal Article ; Review |
| ZDB-ID | 2057357-1 |
| ISSN | 1534-6307 ; 1523-3774 |
| ISSN (online) | 1534-6307 |
| ISSN | 1523-3774 |
| DOI | 10.1007/s11926-022-01064-8 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
| Zs.A 5531: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.
The American journal of nursing
2015 Volume 115, Issue 5, Page(s) 11
| MeSH term(s) | Clinical Nursing Research ; Diffusion of Innovation ; Evidence-Based Nursing ; Humans ; Information Dissemination/methods ; United States |
|---|---|
| Language | English |
| Publishing date | 2015-05 |
| Publishing country | United States |
| Document type | Journal Article |
| ZDB-ID | 390780-6 |
| ISSN | 1538-7488 ; 0002-936X |
| ISSN (online) | 1538-7488 |
| ISSN | 0002-936X |
| DOI | 10.1097/01.NAJ.0000465010.34824.62 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
| Zs.B 948: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.
2016
| Author's details | editor in chief: Marylynn V. Yates ; editors: Cindy H. Nakatsu, Robert V. Miller, Suresh D. Pillai |
|---|---|
| Keywords | Microbial ecology ; Sanitary microbiology |
| Language | English |
| Size | 1 Online-Ressource (1042 Seiten), Illustrationen |
| Edition | Fourth edition |
| Publisher | ASM Press |
| Publishing place | Washington, DC |
| Publishing country | United States |
| Document type | Book ; Online ; E-Book |
| Note | English ; Includes bibliographical references and index |
| Remark | Zugriff für angemeldete ZB MED-Nutzerinnen und -Nutzer |
| HBZ-ID | HT020563739 |
| ISBN | 978-1-683-67323-1 ; 9781555818821 ; 9781555816025 ; 1-683-67323-9 ; 155581882X ; 1555816029 |
| Database | ZB MED Catalogue: Medicine, Health, Nutrition, Environment, Agriculture |
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.
Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.